SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Incyte (INCY)
An SI Board Since January 1996
Posts SubjectMarks Bans Symbol
3202 131 0 INCY
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1727I started to play devil's advocate, and suggest that if you didn't belieA.J. Mullen-3/21/2001
1726Can't add much to that, other than that INCY isn't the only biotech now nigel bates-3/21/2001
1725If I could buy the entire company for $170,000,000 or so technology value would Lighthouse-3/21/2001
1724That's not an intrusion, it's an answer. Hmm. Just watching the trend Raymond Clutts-3/21/2001
1723I do not mean to intrude, but I have been running these numbers myself the past Lighthouse-3/21/2001
1722Nigel, Do you recall the cash valuation of INCY? Wasn't it somewhere arounRaymond Clutts-3/21/2001
1721<You about ready to start rolling your short profits back into BT?> I'LLCF-3/19/2001
1720Dak, Welcolm back. Hopefully this marks the bottom. Got my share in the 14s..smh-3/19/2001
1719Nice to see someone has an eye for a (ridiculous) bargain. nig (edit) You'nigel bates-3/19/2001
1718I'm piling in here... 12 and change. WTF, take my money. DAKLLCF-3/19/2001
1717<i>Genicon Sciences' RLS (Resonance Light Scattering) Technology(TM) wnigel bates-3/13/2001
1716March 7 /PRNewswire/ -- Genomics science is entering a new phase in which progrenigel bates-3/7/2001
1715Fascinating stuff (thanks Mark) - Message 15411284nigel bates-2/26/2001
1714Opal, I'm expecting genetic knowledge to aid in the discovery of new drugs.Torben Noerup Nielsen-2/24/2001
1713<i>Assuming that one of their licencees brings a drug to market, they woulopalapril-2/23/2001
1712Opal, Does it matter in Incyte's case? Assuming that one of their licenceesTorben Noerup Nielsen-2/23/2001
1711chuckle....... <i>These tests will be commercialized by DiaDexus.</i&gscaram(o)uche-2/23/2001
1710Apart from the asteroid problem, I've been wondering if there isn't a fuopalapril-2/23/2001
1709My recollection is that even if we were to value Incyte only for it's cash pRaymond Clutts-2/23/2001
1708Latest risk warning... biz.yahoo.com They did omit mention of the possibility nigel bates-2/23/2001
1707Future Tech - The Great Gene Debate Matthew Herper, sim1-2/21/2001
1706Remember this? "NASDAQ, the stock market for the next hundred years."opalapril-2/20/2001
1705I did compared INCY to "Business Service" company that should be valueNikole Wollerstein-2/20/2001
1704Incyte Defends 'Gene' Claim Following Celera's Lower Estimate Writtsmh-2/17/2001
1703Hi Wilder. Your first point is one I wonder about too, and I don't have anynigel bates-2/16/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News